Overview
- Legal name
- BBG ADVANCED THERAPIES
- Registered location
- SAN ANTONIO, TX, USA
- Website
- Company website ↗
- Primary NAICS
- 325414 — Biological Product (except Diagnostic) Manufacturing
- Latest award activity
- Nov 25, 2024
Read company summary
BBG ADVANCED THERAPIES is associated with UEI L2F8N7ZRYRG7 and CAGE 7BAW2 in public federal records. AcornBids currently links 1 prime award totaling $8.2M in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Blood and Organ Banks. These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 325414 (Biological Product (except Diagnostic) Manufacturing). Its public SAM.gov registration lists SAN ANTONIO, TX, USA.
At a glance
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Aug 20, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- BBG ADVANCED THERAPIES
- UEI
- L2F8N7ZRYRG7
- CAGE
- 7BAW2
- Registered address
- 6211 W INTERSTATE 10, SAN ANTONIO, TX, 78201, USA
- Registration status
- Active
- Primary NAICS
- 325414 — Biological Product (except Diagnostic) Manufacturing
- SAM activation
- Dec 29, 2025
- Initial registration
- Dec 16, 2014
- Entity start
- Mar 6, 2013
- SAM updated
- Dec 29, 2025
- Registration expires
- Dec 23, 2026
- Fiscal year end
- Dec 31
- Place of incorporation
- TX, USA
Federal award analysis
Net transaction obligations by federal fiscal period.
Transaction history is not available in the loaded data. Annual funding is not estimated from current award totals.
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| HHSH234200737009CTAS::75 0350::TAS MGT SVCS/CONTRACT&PROCUREMENT SUP NATIONAL CORD BLOOD INVENTORY AUGMENTATION, SECOND COHORT | Department of Health and Human Services | $8.2M | Sep 13, 2007 | Jun 12, 2026 |
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Dec 29, 2025 |
| Source loaded | Sep 2, 2026 |
| Initial registration | Dec 16, 2014 |
| Entity start | Mar 6, 2013 |
| Industry | Reported size status |
|---|---|
| 325414 — Biological Product (except Diagnostic) Manufacturing | Not reported |
| 621991 — Blood and Organ Banks | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| ADRIENNE MENDOZA | Government business | Contact method not published | SAM registration | Not available |
| BENJAMIN LOPEZ | Electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 325414 — Biological Product (except Diagnostic) Manufacturing
- 621991 — Blood and Organ Banks
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
No official subaward rows are loaded, so Acorn does not claim known teaming relationships.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit